Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study-Reference-Cited by-同舟云学术

Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study

Published:2015-11 Issue:8 Volume:29 Page:1287-1294
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Jaiswal Mamta,Martin Catherine L.,Brown Morton B.,Callaghan Brian,Albers James W.,Feldman Eva L.,Pop-Busui Rodica

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference38 articles.

1. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study;Albers;Diabetes Care,2010

2. Diabetic neuropathy: Mechanisms, emerging treatments, and subtypes;Albers;Current Neurology and Neuroscience Reports,2014

3. Glucose control and diabetic neuropathy: Lessons from recent large clinical trials;Ang;Current Diabetes Reports,2014

4. A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis;Baggio;Diabetes,2004

5. Effect of treatment with sitagliptin on somatosensory-evoked potentials and metabolic control in patients with type 2 diabetes mellitus;Barros;Arquivos Brasileiros de Endocrinologia e Metabologia,2014

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

2. Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management;Diabetologia;2024-08-09

3. Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy;Pathology International;2024-06-18

4. Obesity-related neuropathy: the new epidemic;Current Opinion in Neurology;2024-06-12

5. A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin;Acta Neuropathologica;2024-03-25